Skip to main content
. Author manuscript; available in PMC: 2014 Mar 13.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Aug 21;84(4):1010–1016. doi: 10.1016/j.ijrobp.2012.01.071

Figure 3.

Figure 3

Lyman-Kutcher-Berman model fit by treatment modality among patients receiving >30 fractions of 3-dimensional conformal radiation therapy (3D-CRT), intensity-modulated radiation therapy (IMRT), or proton beam therapy (PBT). NTCP, normal tissue complication probability; Deff, effective (radiation) dose.